Table 3.
Pregnancy characteristics, outcome and characteristics of the newborns of the three supplement groups (n = 116): one boy was born premature in the DHA-FOS group (35 gestational weeks)
| Supplement group |
||||
| Vit/Min (n = 37) | FOS (n = 36) | DHA-FOS (n = 43) | p | |
| Gestational weight gain at 21–37 weeks, kg | 8.7±4.02 (29) | 9.7±2.90 (31) | 9.4±3.71 | 0.518 |
| Length of gestation, weeks | 39.6±2.08 (36) | 39.5±1.65 | 39.0±1.64 | 0.220 |
| Spontaneous delivery, n (%) | 25 (67.6) | 28 (80.0) | 33 (76.7) | 0.446 |
| Newborn sex female, n (%) | 20 (57.1) | 18 (51.4) | 22 (57.9) | 0.835 |
| APGAR ≤7 at 10 min, n (%) | 0 (0) | 0 (0) | 1 (2.3) | 0.230 |
| Cord blood pH ≤7.2, n (%) | 28 (77.8) | 27 (84.4) | 28 (70.7) | 0.385 |
| Newborn weight, kg | 3,5478528.7 | 3,5508408.8 | 3,4278493.6 | 0.422 |
| Newborn length, cm | 52.382.97 | 52.181.93 | 51.382.55 | 0.094 |
| Newborn head circumference, cm | 35.381.14 | 35.381.18 | 35.381.70 | 0.991 |
All applicable values are given as mean ± SD.
No significant difference between groups (one-way ANOVA).